BRAIN Biotech AG

Adriaan Moelker (M)

Vorstandsvorsitzender BRAIN Biotech AG

I am proud to affirm our commitment to advancing gender equality and the empowerment of women in the workplace, marketplace, and community. We recognize that gender equality is not only a moral imperative but also a driver of business success. As a participant of the 6th round of the UN Global Target Gender Accelerator Program, BRAIN Biotech AG examined this topic in depth, increased internal visibility, and derived concrete measures. The resulting WEPs action plan is fully aligned with our integrated ESG-strategy, ensuring initiatives are implemented group-wide and that diversity and gender equality are embedded across all business areas.

General Information

WEPs signatory since 18 February 2026
Public
201-500 employees

Baseline

Between 30% and 50% women employees.

Less than 30% women at management level.

Less than 30% women on boards/executive team/partners.

Industry

Biotechnology

Location

Germany
Europe and Central Asia
Also operating and will implement WEPs in the following countries and regions:
Other Countries
Netherlands
United Kingdom of Great Britain and Northern Ireland
United States of America

Progress - 2026

Percentage of women and men employees
  • 50.00
  • 50
  • 45 - 50%
  • 45 - 50%
Percentage of women and men in senior management positions
  • 26.00
  • 74
  • 26 - 30%
  • 71 - 75%
Percentage of women and men on the company board
  • 37.50
  • 62.5
  • 36 - 40%
  • 61 - 65%
Has a confidential grievance, resolution, reporting and non-retaliation mechanism and procedure to respond to incidents of violence and harassment
Last updated on: 25 March 2026